Concepedia

Author

J. Vinholes

Hospital de Clínicas de Porto Alegre

Also Known As

J Vinholes, J. J. Vinholes, J. Vinholes, J.J. F. Vinholes, J.J.F. Vinholes, Jeferson J. Vinholes, Jeferson J.F. Vinholes, Jeferson Jose Fonseca Vinholes, Jeferson Jose Vinholes, Jeferson Vinholes

50

Publications

5.9K

Citations

21

H-Index

40

Concepts

All Affiliations

Hospital de Clínicas de Porto AlegreWeston Park Cancer CentreHospital General Universitario de ElcheNovartis (Switzerland)Hospital General Universitario Gregorio Marañón
JV

About

J. Vinholes is an author at Hospital de Clínicas de Porto Alegre specializing in medicine, cancer therapeutics, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

18

2.7K

2

Health Sciences

7

7

302

3

Cell Biology

1

1

22

4

Diagnostic Sciences

1

1

10

5

Immunology

1

1

10

J. Vinholes

×

24

Publications

5.5K

Citations

18

H-Index

YearCitations

Long-Term Efficacy of Zoledronic Acid for the Prevention of Skeletal Complications in Patients With Metastatic Hormone-Refractory Prostate Cancer

F. Saad, D. M. Gleason, R. Murray,

JNCI Journal of the National Cancer Institute

2004

1.2K

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky,

The Lancet

2015

1.2K

Adjuvant Docetaxel for Node-Positive Breast Cancer

Miguel Martín, Tadeusz Pieńkowski, John R. Mackey,

New England Journal of Medicine

2005

950

Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study

W. Eiermann, Stefan Paepke, Justus Appfelstaedt,

Annals of Oncology

2001

712

Phase II Randomized Study of Trastuzumab Emtansine Versus Trastuzumab Plus Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

Sara A. Hurvitz, Luc Dirix, Judit Kocsis,

Journal of Clinical Oncology

2013

389

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial

John R. Mackey, Miguel Martín, Tadeusz Pieńkowski,

The Lancet Oncology

2012

221

Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease

J. Vinholes, O.P. Purohit, Mavis Abbey,

Annals of Oncology

1997

169

Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)

Aňa Lluch, Carlos H. Barrios, Laura Torrecillas,

Journal of Clinical Oncology

2019

143

Double-blind, randomised, placebo-controlled, dose-finding study of oral ibandronate in patients with metastatic bone disease

Robert E. Coleman, O.P. Purohit, Casilda G. Black,

Annals of Oncology

1999

95

Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy.

J. Vinholes, Chun Guo, O.P. Purohit,

Journal of Clinical Oncology

1997

75

Page 1